as on February 10, 2026 at 9:31 pm IST
Day's Low
Day's High
0.93%
Downside
3.17%
Upside
52 Week's Low
52 Week's High
42.76%
Downside
25.77%
Upside
as on February 10, 2026 at 4:01 pm IST
Market Cap
₹9,056.33 Cr
Return on Equity (ROE)
1.42
PE Ratio (TTM)
66.69
Return on capital employed (ROCE)
2.23
Industry PE ratio
40.65
Beta (LTM)
1.41
P/B Ratio
2.87
Dividend Yield
0PEG Ratio
38.33
Quarterly Earnings Growth YOY
15.69
EPS (TTM)
1.29
Sector
Pharmaceuticals
Book Value
28.15
Technical Analysis
Bearish
View Technical Analysis
as on February 10, 2026 at 4:01 pm IST
Sequent Scientific in the last 5 years
Lowest (-117.80x)
January 17, 2023
Industry (40.65x)
February 9, 2026
Today (66.69x)
February 9, 2026
Highest (1034.67x)
September 27, 2024
Today’s Price to Earnings Ratio: 66.69x
Compare market cap, revenue, PE, and other key metrics of Sequent Scientific with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 9,056.33 | -3.18% | 0.72 | 32 | 1,551 | |
| NA | 127.16 | 62.63% | 0.00 | 5 | 116 | |
| NA | 33.96 | -3.15% | 0.78 | -13 | 92 | |
| NA | 197.71 | 12.17% | 0.00 | 4 | 473 | |
| NA | 14.25 | 31.72% | 0.00 | -2 | 5 |
Get share price movements and forecasts by analysts on Sequent Scientific.
Source: S&P Global Market Intelligence
Search interest for Viyash Scientific Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sequent Scientific.
Viyash Scientific Ltd’s net profit fell -13.83% since last year same period to ₹38.44Cr in the Q3 2025-2026. On a quarterly growth basis, Viyash Scientific Ltd has generated -29.99% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2021, Viyash Scientific Ltd has declared dividend of ₹0.50 per share on 30 Jun 2021 - translating a dividend yield of 0.24%.
Read More about DividendsCheck stock indices that include Sequent Scientific.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 403.36 Cr → 872.39 Cr (in ₹), with an average increase of 19.7% per quarter
Promoter Holding Up
![]()
Promoters have increased holdings from 52.33% to 61.41% in Dec 2025 quarter
Best in 1 Year
![]()
In the last 1 year, VIYASH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
![]()
In the last 3 years, VIYASH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Down
![]()
Retail Investor have decreased holdings from 28.69% to 27.97% in Dec 2025 quarter
Price Dip
![]()
In the last 7 days, VIYASH stock has moved down by -2.5%
MF Holding Down
![]()
Mutual Funds have decreased holdings from 10.04% to 5.82% in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 54.91 Cr → 38.44 Cr (in ₹), with an average decrease of 30.0% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 5.91% to 3.16% in Dec 2025 quarter
| Organisation | Viyash Scientific Ltd |
| Headquarters | Bangalore |
| Industry | Pharmaceuticals |
| CEO | Kamal K Sharma |
| E-voting on shares | Click here to vote |
Sequent Scientific share price today stands at ₹205.01 as on at the close of the market. Sequent Scientific share today touched a day high of ₹211.51 and a low of ₹203.1.
Sequent Scientific touched a 52 week high of ₹257.85 and a 52 week low of ₹117.35. Sequent Scientific share price today i.e. is closed at ₹205.01, which is -20.49% down from its 52 week high and 74.70% up from its 52 week low.
Sequent Scientific market capitalisation is ₹9,056.33 Cr as on .
To buy Sequent Scientific shares, you need to follow these steps:
Sequent Scientific trading volume is 5.33L as on . This means that 5.33L shares of Sequent Scientific were bought and sold on the stock market during today's trading session.